We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+12.19%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$63.2B
AUM Growth
+$4.44B
(+7.5%)
Cap. Flow
-$400M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
37.48%
Holding
990
New
39
Increased
448
Reduced
439
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$105M |
| 2 |
Amazon
AMZN
|
+$95.9M |
| 3 |
Apple
AAPL
|
+$86.7M |
| 4 |
Walmart Inc
WMT
|
+$64.8M |
| 5 |
GE Aerospace
GE
|
+$48.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Southern Copper
SCCO
|
+$157M |
| 2 |
Tesla
TSLA
|
+$129M |
| 3 |
UnitedHealth
UNH
|
+$106M |
| 4 |
Fomento Económico Mexicano
FMX
|
+$103M |
| 5 |
Microsoft
MSFT
|
+$69.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.37% |
| 2 | Healthcare | 12.36% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Communication Services | 10.58% |
| 5 | Financials | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Korro Bio
KRRO
$145M
| $2.78M | ﹤0.01% |
57,983
-26,445
| -31% | -$587K |
|
752
Rhythm Pharmaceuticals
RYTM
$7.31B
| $2.7M | ﹤0.01% |
26,740
-40,917
| -60% | -$3.8M |
|
753
Coca-Cola Europacific Partners
CCEP
$49.1B
| $2.69M | ﹤0.01% |
29,734
-8,478
| -22% | -$787K |
|
754
Ares Capital
ARCC
$13.4B
| $2.63M | ﹤0.01% |
130,322
+729
| +0.6% | +$16.2K |
|
755
Petrobras Class A
PBR.A
$106B
| $2.62M | ﹤0.01% |
220,268
+100,297
| +84% | +$1.16M |
|
756
Agree Realty
ADC
$9.66B
| $2.61M | ﹤0.01% |
37,002
+4,492
| +14% | +$325K |
|
757
STAG Industrial
STAG
$7.44B
| $2.59M | ﹤0.01% |
74,173
+7,878
| +12% | +$281K |
|
758
Blue Owl Capital
OBDC
$5.35B
| $2.57M | ﹤0.01% |
202,091
| – | – |
|
759
Alcon
ALC
$34B
| $2.54M | ﹤0.01% |
+34,326
| New | +$2.86M |
|
760
Zillow
ZG
$7.85B
| $2.53M | ﹤0.01% |
+33,980
| New | +$2.67M |
|
761
Lucid Diagnostics
LUCD
$175M
| $2.52M | ﹤0.01% |
+2,500,000
| New | +$2.73M |
|
|
DQ
762
Daqo New Energy
DQ
$810M
| $2.48M | ﹤0.01% |
87,591
-1,349
| -2% | -$31.6K |
|
763
TScan Therapeutics
TCRX
$48.5M
| $2.47M | ﹤0.01% |
1,354,820
+463,372
| +52% | +$821K |
|
|
NVMI
764
Nova
NVMI
$11.7B
| $2.44M | ﹤0.01% |
7,628
-73,647
| -91% | -$20.3M |
|
765
Corbus Pharmaceuticals
CRBP
$165M
| $2.38M | ﹤0.01% |
188,231
+116,005
| +161% | +$1.1M |
|
766
Essential Properties Realty Trust
EPRT
$6.92B
| $2.35M | ﹤0.01% |
79,303
+8,305
| +12% | +$254K |
|
|
MPT
767
Medical Properties Trust
MPT
$2.84B
| $2.29M | ﹤0.01% |
462,151
-123,177
| -21% | -$543K |
|
768
First Industrial Realty Trust
FR
$8.66B
| $2.26M | ﹤0.01% |
43,805
+5,318
| +14% | +$267K |
|
769
Full Truck Alliance
YMM
$10B
| $2.25M | ﹤0.01% |
172,228
-47,985
| -22% | -$594K |
|
770
Paycom
PAYC
$7.88B
| $2.24M | ﹤0.01% |
10,265
-34
| -0.3% | -$7.66K |
|
771
Invesco QQQ Trust
QQQ
$436B
| $2.2M | ﹤0.01% |
3,676
+2,854
| +347% | +$1.63M |
|
772
Apogee Therapeutics
APGE
$10.1B
| $2.18M | ﹤0.01% |
+54,760
| New | +$2.09M |
|
773
Park Hotels & Resorts
PK
$3.08B
| $2.15M | ﹤0.01% |
194,742
+78,373
| +67% | +$881K |
|
774
Skyworks Solutions
SWKS
$9.2B
| $2.13M | ﹤0.01% |
27,706
-130,364
| -82% | -$9.71M |
|
775
Disc Medicine
IRON
$2.81B
| $2.12M | ﹤0.01% |
32,061
| – | – |
|
Similar funds
Aberdeen Group's Q3 2025 Portfolio in Review
As of Q3 2025, Aberdeen Group held 990 positions worth $63.2B, up 7.5% from $58.8B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Aberdeen Group's Q3 2025 filing shows 39 new, 448 increased, 439 reduced and 38 closed positions. Its largest new stake was Hesai Group: 1,365,740 shares worth $38.2M. The largest sale was Southern Copper, an estimated $157M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Aberdeen Group's largest Q3 2025 buy was Hesai Group: 1,365,740 shares worth $38.2M.
- Aberdeen Group added most to Wells Fargo in Q3 2025, an estimated $105M increase.
- Aberdeen Group's biggest Q3 2025 reduction was Southern Copper, cutting an estimated $157M.
- Aberdeen Group fully exited Ansys in Q3 2025, selling an estimated $28.5M.
- Aberdeen Group's ten largest holdings make up 37% of its $63.2B portfolio in Q3 2025.
- Aberdeen Group opened 39 new positions and closed 38 in Q3 2025.
- Aberdeen Group's portfolio value rose 7.5% quarter-over-quarter to $63.2B.
Based on Aberdeen Group's 13F filing for Q3 2025, filed 7 Nov 2025.